Aryx Therapeutics Other Current Liabilities

Aryx Therapeutics (ARYX) currently reports a other current liabilities of $730K as of September 2010. That compares with $2.1M in the prior-year period — down 64.6% year over year. Use the charts on this page to explore Aryx Therapeutics's other current liabilities history and peer comparisons.

Aryx Therapeutics's other current liabilities decreased from $2.1M to $730K — a 64.6% year-over-year decrease (period ending September 2010). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aryx Therapeutics reported $730K in other current liabilities as of September 2010. That compares with $2.1M in the prior-year period — down 64.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $730K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aryx Therapeutics, and consider following ARYX for alerts when major investors trade the stock.

Aryx Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $730K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARYX with unrelated industries.